Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dovitinib in Recurrent/Metastatic Adenoid Cystic Carcinoma
NCT01678105Phase 2Completed
- Sponsor
- Ontario Clinical Oncology Group
- Start
- Nov 2012
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dovitinib in adenoid cystic carcinoma (ACC), sponsored by Ontario Clinical Oncology Group. Started Nov 2012; status: completed.
02
Drugs
dovitinib
03
Conditions
adenoid cystic carcinoma (ACC)
Beyond the preview
Go deeper on NCT01678105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01678105.